1. Home
  2. IART vs SYRE Comparison

IART vs SYRE Comparison

Compare IART & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Integra LifeSciences Holdings Corporation

IART

Integra LifeSciences Holdings Corporation

HOLD

Current Price

$13.23

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Logo Spyre Therapeutics Inc.

SYRE

Spyre Therapeutics Inc.

HOLD

Current Price

$33.85

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IART
SYRE
Founded
1989
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.1B
IPO Year
1995
2016

Fundamental Metrics

Financial Performance
Metric
IART
SYRE
Price
$13.23
$33.85
Analyst Decision
Hold
Strong Buy
Analyst Count
7
4
Target Price
$15.00
$55.50
AVG Volume (30 Days)
874.9K
652.6K
Earning Date
10-30-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,642,966,000.00
N/A
Revenue This Year
$3.26
N/A
Revenue Next Year
$2.71
N/A
P/E Ratio
N/A
N/A
Revenue Growth
4.99
N/A
52 Week Low
$10.87
$10.91
52 Week High
$27.13
$34.54

Technical Indicators

Market Signals
Indicator
IART
SYRE
Relative Strength Index (RSI) 53.66 78.25
Support Level $12.81 $28.16
Resistance Level $13.43 $34.54
Average True Range (ATR) 0.57 1.94
MACD 0.24 0.70
Stochastic Oscillator 78.69 92.54

Price Performance

Historical Comparison
IART
SYRE

About IART Integra LifeSciences Holdings Corporation

Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

Share on Social Networks: